tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Algernon Pharmaceuticals announces name change to Algernon Health
PremiumThe FlyAlgernon Pharmaceuticals announces name change to Algernon Health
2M ago
Algernon Pharmaceuticals Closes Private Placement Financing to Advance Alzheimer’s Initiative
Premium
Company Announcements
Algernon Pharmaceuticals Closes Private Placement Financing to Advance Alzheimer’s Initiative
3M ago
Algernon Pharmaceuticals Amends Private Placement Terms and Closes First Tranche
Premium
Company Announcements
Algernon Pharmaceuticals Amends Private Placement Terms and Closes First Tranche
4M ago
Algernon Pharmaceuticals Extends Warrant Expiry Date to November 2025
PremiumCompany AnnouncementsAlgernon Pharmaceuticals Extends Warrant Expiry Date to November 2025
6M ago
Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial
Premium
The Fly
Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial
7M ago
Algernon Pharmaceuticals receives notice of allowance from EPO for Repirinast
Premium
The Fly
Algernon Pharmaceuticals receives notice of allowance from EPO for Repirinast
7M ago
Psychedelic: Relmada acquires neurosteroid from Asarina
PremiumThe FlyPsychedelic: Relmada acquires neurosteroid from Asarina
9M ago
Algernon Pharmaceuticals appoints Validcare as CRO for Phase 2a DMT trial
Premium
The Fly
Algernon Pharmaceuticals appoints Validcare as CRO for Phase 2a DMT trial
9M ago
Algernon Pharmaceuticals Secures Patent for Lead CKD Drug
Premium
Company Announcements
Algernon Pharmaceuticals Secures Patent for Lead CKD Drug
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100